Safinamide Methanesulfonate

DRUG2 trials

Sponsors

Zambon SpA

Conditions

Idiopathic Parkinson DiseaseMultiple System Atrophy

Phase 2

Safinamide for Multiple System Atrophy (MSA)

CompletedNCT03753763

Zambon SpAMultiple System Atrophy

Start: 2019-10-29End: 2021-01-05Updated: 2021-10-13

Phase 4

Effect of Safinamide on Parkinson's Disease Related Chronic Pain

CompletedNCT03841604

Zambon SpAIdiopathic Parkinson Disease

Start: 2019-04-09End: 2021-05-03Updated: 2023-05-22